Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and internationally. The company is headquartered in Billerica, Massachusetts.
| Revenue (TTM) | $3.51B |
| Gross Profit (TTM) | $1.71B |
| EBITDA | $548.30M |
| Operating Margin | 9.68% |
| Return on Equity | -4.79% |
| Return on Assets | 3.26% |
| Revenue/Share (TTM) | $23.07 |
| Book Value | $15.12 |
| Price-to-Book | 3.83 |
| Price-to-Sales (TTM) | 2.66 |
| EV/Revenue | 2.97 |
| EV/EBITDA | 19.40 |
| Quarterly Earnings Growth (YoY) | -81.80% |
| Quarterly Revenue Growth (YoY) | 1.60% |
| Shares Outstanding | $152.36M |
| Float | $103.78M |
| % Insiders | 26.97% |
| % Institutions | 94.97% |
Volatility is currently expanding
Bruker NASDAQ: BRKR reported third-quarter 2026 revenue growth of 1.6% to $874 million, while non-GAAP earnings per share rose 24.4% year over year to $0.56 as cost-saving actions and favorable product mix supported margin expansion.
Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Bruker (BRKR) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.45 per share a year ago.
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2026 financial results before market opening on Wednesday, November 4, 2026. The Company will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q3 2026 Earnings Webcast” hyperlink in the “Events & Presentations” section. A.
BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.
BERLIN--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced a seminal bioRxiv preprint, describing a draft atlas of the human plasma proteome at isoform, or proteoform, resolution. The study was conducted by principal investigator Markus Ralser at Charité – Universitätsmedizin Berlin and collaborators. The preprint “A draft atlas of the human plasma proteome at isoform resolution” was posted on September 28, 2026 at https://doi.org/10.64898/2026.09.26.754256. By combining intact protei.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
SINGAPORE--(BUSINESS WIRE)---- $BRKR #BRKR--At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF dis.
Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
BERKELEY, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz–class instrumentation. These capabilities strengthen research in chemistry, materials science, structural biology, and related fields across UC Berkeley an.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BRKR and any ticker you trade — then tracks every position and per-strategy win rate.
